Stem definition | Drug id | CAS RN |
---|---|---|
3400 | 112-80-1 |
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
None | FDA |
None
None
None
None
Source | Code | Description |
---|---|---|
CHEBI has role | CHEBI:22586 | antioxidants |
CHEBI has role | CHEBI:46787 | solvents |
CHEBI has role | CHEBI:75771 | Mus musculus metabolites |
CHEBI has role | CHEBI:76924 | plant metabolites |
CHEBI has role | CHEBI:76971 | Escherichia coli metabolites |
CHEBI has role | CHEBI:78444 | Alpha-carboxylesterase inhibitor |
CHEBI has role | CHEBI:83038 | Daphnia galeata metabolites |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Sensation Disturbance of Genitals | contraindication |
Species | Use | Relation |
---|---|---|
Horses | Stimulates infiltration of cellular blood components that subsequently differentiate into fibrous and/or fibrocartilaginous tissue | Indication |
Product | Applicant | Ingredients |
---|---|---|
Osteum Solution 50 mg | Summit Hill Laboratories | 1 |
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 4.76 | acidic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Fatty-acid amide hydrolase 1 | Enzyme | Ki | 5.22 | CHEMBL | |||||
Aromatase | Enzyme | IC50 | 4.49 | CHEMBL | |||||
Peroxisome proliferator-activated receptor alpha | Nuclear hormone receptor | IC50 | 6.22 | CHEMBL | |||||
Peroxisome proliferator-activated receptor gamma | Nuclear hormone receptor | IC50 | 5.39 | CHEMBL | |||||
Tyrosine-protein phosphatase non-receptor type 1 | Enzyme | IC50 | 5.21 | CHEMBL | |||||
Fatty acid-binding protein, adipocyte | Cytosolic other | Ki | 6.73 | CHEMBL | |||||
DNA topoisomerase 1 | Enzyme | IC50 | 4.51 | CHEMBL | |||||
Telomerase reverse transcriptase | Enzyme | IC50 | 5.07 | CHEMBL | |||||
Fatty acid-binding protein, epidermal | Cytosolic other | Ki | 6.61 | CHEMBL | |||||
Peroxisome proliferator-activated receptor delta | Nuclear hormone receptor | IC50 | 5.28 | CHEMBL | |||||
Free fatty acid receptor 1 | GPCR | AGONIST | EC50 | 5.70 | IUPHAR | ||||
Fatty acid-binding protein, liver | Unclassified | Kd | 6.70 | CHEMBL | |||||
Tissue factor | Membrane receptor | IC50 | 4.10 | CHEMBL | |||||
Free fatty acid receptor 4 | GPCR | AGONIST | EC50 | 4.70 | IUPHAR | ||||
Nuclear receptor subfamily 4 group A member 2 | Nuclear other | Kd | 4.30 | CHEMBL | |||||
Fatty acid-binding protein, liver | Unclassified | Ki | 6.74 | CHEMBL | |||||
Seed linoleate 13S-lipoxygenase-1 | Enzyme | Ki | 4.66 | CHEMBL |
ID | Source |
---|---|
4020299 | VUID |
N0000148167 | NUI |
4020299 | VANDF |
C0028928 | UMLSCUI |
CHEBI:16196 | CHEBI |
OLA | PDB_CHEM_ID |
CHEMBL8659 | ChEMBL_ID |
DB04224 | DRUGBANK_ID |
D019301 | MESH_DESCRIPTOR_UI |
445639 | PUBCHEM_CID |
1054 | IUPHAR_LIGAND_ID |
2UMI9U37CP | UNII |
70616 | RXNORM |
NOCODE | MMSL |
002530 | NDDF |
259579007 | SNOMEDCT_US |
427281002 | SNOMEDCT_US |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Sha-lem | HUMAN OTC DRUG LABEL | 5 | 59862-100 | OINTMENT | 14.50 g | TOPICAL | unapproved drug other | 10 sections |